Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city

Background Diabetes mellitus (DM) is one of the leading chronic diseases globally and one of the most common causes of death, morbidity, and poor quality of life. According to the WHO, DM is also one of the main risk factors for developing active tuberculosis (TB). Subjects with DM are at a higher risk of infections, in addition to frequent micro and macrovascular complications, and therefore sought to determine whether poor glycemic control is linked to a higher risk of developing TB. Methods We used a retrospective cohort of diabetic subjects to predict the incidence of TB. All DM patients were recruited from Ciutat Vella (the inner-city of Barcelona) from January 2007 until December 2016, with a follow-up period until December 2018 (≥2 years). Data were extracted from Barcelona's Primary Care medical record database - SIDIAP, and linked to the Barcelona TB Control Program. The incidence of TB and the impact of glycemic control were estimated using time-to-event curves analyzed by Cox proportional hazard regression. Hazard ratios (HRs) and 95% confidence intervals (CIs), unadjusted and adjusted by potential confounding variables, were also assessed, which included age, sex, diabetes duration, macrovascular and microvascular signs, BMI, smoking habit, alcohol consumption and geographical origin. Results Of 8,004 DM patients considered for the study (equating to 68,605 person-years of follow-up), 84 developed TB [incidence rate = 70 (95% CI: 52–93) per 100,000 person-years]. DM subjects with TB were younger (mean: 52.2 vs. 57.7 years old), had higher values of glycosylated hemoglobin (HbA1c) (7.66 vs. 7.41%) and total triglycerides (122 vs. 105 mg/dl), and had twice the frequency of diabetic nephropathy (2.08 vs. 1.18%). The calculated incidence rate increased with increasing HbA1c: 120.5 (95% CI 77.2–179.3) for HbA1c ≥ 7.5%, 143 (95% CI 88.3–218.1) for HbA1c ≥ 8% and 183.8 (95% CI 105–298) for HbA1c ≥ 9%. An increase in the risk of TB was also observed according to a poorer optimization of glycemic control: adjusted HR 1.80 (95% CI 0.60–5.42), 2.06 (95% CI 0.67–6.32), and 2.82 (95% CI 0.88–9.06), respectively. Conclusion Diabetic subjects with worse glycemic control show a trend toward a higher risk of developing TB.

[1]  D. van Soolingen,et al.  The impact of diabetes mellitus on pulmonary TB. , 2022, Public Health Action.

[2]  A. Orcau,et al.  Subjects With Diabetes Mellitus Are at Increased Risk for Developing Tuberculosis: A Cohort Study in an Inner-City District of Barcelona (Spain) , 2022, Frontiers in Public Health.

[3]  D. Yanifitri,et al.  High glycosylated hemoglobin level as a risk factor of latent tuberculosis infection in patients with uncomplicated type 2 diabetes mellitus , 2022, Universa Medicina.

[4]  P. Preux,et al.  DECREASE OF GLYCATED HEMOGLOBIN BASED ON EVALUATION OF DIABETES INTERVENTION PROGRAMS IN LOW-AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW , 2022, Diabetes Epidemiology and Management.

[5]  Ranran Song,et al.  The association of glycemic level and prevalence of tuberculosis: a meta-analysis , 2021, BMC Endocrine Disorders.

[6]  E. Schouten,et al.  Risk of having pulmonary tuberculosis in type 2 diabetes: A hospital-based matched case-control study. , 2021, Asia Pacific Journal of Clinical Nutrition.

[7]  J. A. Caylà,et al.  Diabetes y tuberculosis: una sindemia complicada por la COVID-19 , 2021, Medicina Clínica.

[8]  Tewodros Shibabaw,et al.  Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis , 2019, Journal of immunology research.

[9]  J. Critchley,et al.  The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. , 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  D. Cook,et al.  Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study , 2018, Diabetes Care.

[11]  J. Valcour,et al.  Diabetes and the occurrence of infection in primary care: a matched cohort study , 2018, BMC Infectious Diseases.

[12]  M. Castellanos,et al.  Glycemic Control and the Prevalence of Tuberculosis Infection: A Population-based Observational Study , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Shi-chuan Chang,et al.  The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients , 2017, PloS one.

[14]  A. Elliot,et al.  Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[15]  V. Mahishale,et al.  Effect of Poor Glycemic Control in Newly Diagnosed Patients with Smear-Positive Pulmonary Tuberculosis and Type-2 Diabetes Mellitus , 2017, Iranian journal of medical sciences.

[16]  D. Mauricio,et al.  Is diabetes mellitus correctly registered and classified in primary care? A population-based study in Catalonia, Spain. , 2016, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[17]  Hsien-Ho Lin,et al.  Glycemic Control and the Risk of Tuberculosis: A Cohort Study , 2016, PLoS medicine.

[18]  P. Kearney,et al.  Risk Factors for Macro- and Microvascular Complications among Older Adults with Diagnosed Type 2 Diabetes: Findings from The Irish Longitudinal Study on Ageing , 2016, Journal of diabetes research.

[19]  R. Kempker,et al.  Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis , 2016, Open forum infectious diseases.

[20]  M. Casals,et al.  Factors associated with diabetes mellitus among adults with tuberculosis in a large European city, 2000-2013. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  L. Smeeth,et al.  Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink , 2015, BMC Medicine.

[22]  Jen-Jyh Lee,et al.  The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis , 2015, PloS one.

[23]  Isaac Subirana,et al.  Building Bivariate Tables: The compareGroups Package for R , 2014 .

[24]  Jen-Jyh Lee,et al.  Glycemic Control and Radiographic Manifestations of Tuberculosis in Diabetic Patients , 2014, PloS one.

[25]  W. Haas,et al.  Epidemiology of tuberculosis in big cities of the European Union and European Economic Area countries. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  Hsing-Yi Chang,et al.  The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  H. Sørensen,et al.  Diabetes, Glycemic Control, and Risk of Tuberculosis , 2011, Diabetes Care.

[28]  L. Anibarro,et al.  [Consensus document on the diagnosis, treatment and prevention of tuberculosis]. , 2010, Archivos de bronconeumologia.

[29]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[30]  M. Murray,et al.  Correction: Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies , 2008, PLoS Medicine.

[31]  G. Leung,et al.  Diabetic control and risk of tuberculosis: a cohort study. , 2008, American journal of epidemiology.

[32]  M. F. Domínguez-Berjón,et al.  Construcción de un índice de privación a partir de datos censales en grandes ciudades españolas (Proyecto MEDEA) , 2008 .

[33]  Peter Jüni,et al.  Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. , 2006, American heart journal.

[34]  F. Schellevis,et al.  Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  J. Hux,et al.  Quantifying the risk of infectious diseases for people with diabetes. , 2003, Diabetes care.

[36]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[37]  A. Dreher Modeling Survival Data Extending The Cox Model , 2016 .

[38]  K. Shadan,et al.  Available online: , 2012 .